RNA Therapies on the Rise—and Data Challenges, Too
Ming Wang April 24, 2023
Unlocking the Power of Posit and R for Precision Medicine Development
Marie-Ange Kouassi & Hagen Klett February 27, 2023
R&D Digitalization: Industry Perspectives from the Open Forum at EMD Serono
Jana Hersch November 17, 2022
Genedata at Bio Japan 2022
Naho Shimoyama November 9, 2022
Uniting to Transform Biotherapeutic Product QC with NGS
Marie-Ange Kouassi October 30, 2022
Interview: Automated Screening for COVID-19 Drugs
Jasmin Lozza October 17, 2022
Modern AI Technologies for Label Free Live Cell Imaging
Cameron Scott, Ph.D. October 13, 2022
Comprehensive Viral Detection in Biologics Manufacturing
Marie-Ange Kouassi October 6, 2022
Collaboration and Digitalization Fuel Biopharma Innovation
Jana Hersch September 25, 2022
On the Path to Precision in Alzheimer’s Disease Management
Justyna Lisowska September 21, 2022
Foster Open Innovation for Cell Therapy Development
Justyna Lisowska July 19, 2022
Discussions on Optimizing Cell Line Development with NGS
Marie-Ange Kouassi July 18, 2022
Accelerated mAb Manufacturing: 3 Months to GMP
Marie-Ange Kouassi June 24, 2022
Advance Translational Research with a Powerful Data Inventory
Marie-Ange Kouassi June 9, 2022
Using TLA for Genomic Fingerprinting of Production Cell Lines
Marie-Ange Kouassi April 24, 2022
Leveraging a Data Strategy for Improved Clinical Success Rates
Lakshmi Maithel March 29, 2022
Unusual Biological Product Characteristic Identified with NGS
Marie-Ange Kouassi March 10, 2022
Fireside Discussions on NGS-Based Biosafety - A Gamechanger
Marie-Ange Kouassi February 8, 2022
World Cancer Day at Genedata
Genedata February 4, 2022
Facilitating Knowledge Exchange on NGS-Based Biosafety Testing
Marie-Ange Kouassi December 9, 2021
Going Beyond a Biomarker-Driven Strategy
Justyna Lisowska November 30, 2021
Screener User Community Comes Together
Ada Yee October 13, 2021
Leveraging Data on the Journey to Successful Cell Therapy
Justyna Lisowska & Marie-Ange Kouassi September 29, 2021
Interview: Bispecific Development at Amgen
Ada Yee September 1, 2021
Artificial Intelligence, Mass Spec, and COVID-19: Best of SLAS Europe
Ada Yee July 1, 2021
Knowledge Exchange on NGS-Based Cell Line Development
Marie-Ange Kouassi May 28, 2021
ASGCT Highlights: Advancements in Cell and Gene Therapy
Cristal Reyna Thompson May 27, 2021
Leveraging Technology for Integrative Approaches in IMIDs
Justyna Lisowska & Marie-Ange Kouassi May 5, 2021
Four Big Takeaways from the IO360° Conference
Cristal Reyna Thompson March 30, 2021
Endotyping: The Path to Precision Medicine for IMIDs
Marie-Ange Kouassi March 22, 2021
Our Team’s Favorite SLAS2021 Talks
Ada Yee February 23, 2021
Searching for COVID-19 Treatments with HCS
Ada Yee July 28, 2020
Deep Learning-Based HCS Image Analysis—Our Paper is Out!
Stephan Steigele May 22, 2020
Lab of the Future Congress: My Top 3 Takeaways
Kevin Teburi November 19, 2019
How Cell Line Variability Impacts Screening
Ada Yee December 28, 2018
High Content Screening for Drug Repurposing: A New Resource
Ada Yee December 14, 2018
Genedata Screener Paper Highlights 2018
Genedata December 11, 2018
2018 Nobel Prizes - The Year of the Antibody
Genedata October 4, 2018
